Home Your basket
• The symphonix symposium u...
   Price 8.50 €
• Hypersensitivity to inhal...
   Price 10.50 €
• Congenital cholesteatoma ...
   Price 5.50 €
• A survey of current wound...
   Price 5.50 €
• Interstitial brachytherap...
   Price 8.50 €
• Bullet in the pharynx: En...
   Price 10.50 €
• Surgical procedure in fir...
   Price 8.50 €
• Rhinoplasty: Morphodynami...
   Price 10.50 €
• Ruptured pexis after supr...
   Price 10.50 €
• Use of a laryngeal mask d...
   Price 8.50 €
• Autistic like behaviour d...
   Price 8.50 €
• Benign paroxysmal positio...
   Price 10.50 €
• Cervical cystic lymphangi...
   Price 5.50 €
• Lingual granuloma of preg...
   Price 5.50 €
• Paediatric endoscopic sin...
   Price 10.50 €
• IPSEN Foundation meeting:...
   Price 5.50 €
• A clinico-radiological st...
   Price 10.50 €
• The effectiveness of voic...
   Price 14.00 €
• Endoscopic ligation of th...
   Price 12.00 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• Meniere disease : news....
   Price 10.50 €
• Adaptation and validation...
   Price 10.50 €
• Oto-rhino-laryngology and...
   Price 10.50 €
• Quality of life evaluatio...
   Price 10.50 €
• Reconstruction of bone de...
   Price 10.50 €
• Psychosocial quality of l...
   Price 10.50 €
• Amphicrine adenoma of the...
   Price 8.50 €
• The «neurological» velum ...
   Price 14.00 €
• Vibrant Soundbridge for h...
   Price 10.50 €
• Transit time of swallowin...
   Price 10.50 €
• Artistic anatomy of the n...
   Price 8.50 €

Total Order 290.00 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 1 - 2010 o

PHONIATRICS

Voice related quality of life after botulinum toxin injection for spasmodic dysphonia


Authors : Gama A. C. C. 1<br />Menezes LN, Maia AA, Rezende Neto AL, Oliveira JB. (Belo Horizonte)

Ref. : Rev Laryngol Otol Rhinol. 2010;131,1:39-44.

Article published in english
Downloadable PDF document english



Summary : Introduction: Laryngeal Focal Dystonia (LFD) leads to a type of voice with a strained and tense quality which has a neurological origin, affecting the social-emotional realms of the individuals, and their quality of life. Aims: Measure the voice-related quality of life of patients with Adductor LFD pre and post-treatment with Botox®‚ injection followed by voice therapy, using the Voice-Related Quality of Life (V-RQOL). Study Design: Prospective study. Methods: Adductor 11 female patients aged between 33 and 74 years with a diagnosis of Adductor LFD were evaluated. All patients underwent a neurological evaluation. Laryngoscopy was performed with both rigid and flexible endoscopes. Speech and Language evaluation followed the Evaluation of Voice Protocol, proposed by Behlau, Pontes (1995). The American V-RQOL measure was utilized. Results: Statistical analysis demonstrated significant difference (p< 0,05). 81.8% of patients showed higher scores post-Botox®‚ for the social-emotional and physical domain. In the overall V-RQOL scores 72.7% of patients showed greater scores post-treatment. Conclusions: There was an improvement in the quality of life for these patients post-treatment. The V-RQOL proved to be an efficient tool to measure the treatment outcomes of LFD pre and post botulinum toxin injection.

Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE